Jim Cramer says he believes we are today better prepared for both the terror and the financial attacks that America endured on 9/11.

Jim Cramer weighs in on Cypress Semiconductor, Omeros, Zuora, Kemet, Leidos, Raytheon, and Skyworks Solutions.

Despite lobbying hard for changes, the pharmaceutical industry is going to cover more costs regarding Medicare Part D in the $1.3 trillion budget that needs to pass by Friday.

The Seattle firm said Aug. 21 it completed an underwritten public offering of 3 million shares priced at $22.75 apiece.

BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.

Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.

OncoMed Pharmaceuticals, Incyte and Omeros were among the biotech stock movers in premarket trading on Monday.

Jim Cramer says hold off before jumping into Freeport McMoRan, Wix.com and Zions Bancorporation.

Jim Cramer stresses discipline here because, he says, a frothy market can quickly turn on investors.

Amyris is showing progress in one key area, but it may not be enough.

The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.

The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.